Re: ANDS results in genotype 1a vs. 1b HCV patients
What is the difference between genotype 1a and 1b HCV patients as far as market size? If the bulk of patients are 1a, I might be concerned as the drug was clearly more potent in the 1b type, although it was clearly active in 1a.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.